Deutsche Bank set a €5.50 ($6.40) price target on ElringKlinger (ETR:ZIL2) in a report published on Wednesday, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.
ZIL2 has been the topic of a number of other reports. Warburg Research set a €60.00 ($69.77) price target on Compugroup Medical and gave the stock a neutral rating in a research note on Tuesday, May 7th. Kepler Capital Markets restated a hold rating on shares of Continental in a research note on Friday, June 28th. JPMorgan Chase & Co. set a $60.00 price target on Bayerische Motoren Werke and gave the stock a sell rating in a research note on Monday, April 8th. DZ Bank restated a sell rating on shares of ElringKlinger in a research note on Wednesday, May 8th. Finally, Independent Research set a €5.60 ($6.51) price target on ElringKlinger and gave the stock a sell rating in a research note on Tuesday, May 21st. Ten analysts have rated the stock with a sell rating and two have given a hold rating to the stock. ElringKlinger has an average rating of Sell and an average price target of €6.12 ($7.11).
ETR:ZIL2 opened at €5.25 ($6.10) on Wednesday. The company has a quick ratio of 0.86, a current ratio of 1.85 and a debt-to-equity ratio of 95.20. The stock’s fifty day moving average price is €5.35. ElringKlinger has a 52 week low of €5.03 ($5.85) and a 52 week high of €11.81 ($13.73). The firm has a market capitalization of $332.64 million and a PE ratio of 20.04.
ElringKlinger Company Profile
ElringKlinger AG develops, manufactures, and distributes technical and chemical products for the automotive sector and the general manufacturing industry worldwide. It operates through five segments: Original Equipment, Aftermarket, Engineered Plastics, Services, and Industrial Parks. The Original Equipment segment develops, manufactures, and sells lightweight components, thermal and acoustic shielding systems, cylinder-head and specialty gaskets, battery and fuel cell systems, and electric drive units.
Further Reading: Are all No-Load Funds Equal?
Receive News & Ratings for ElringKlinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ElringKlinger and related companies with MarketBeat.com's FREE daily email newsletter.